These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26903278)

  • 1. Statin adjunctive therapy shortens the duration of TB treatment in mice.
    Dutta NK; Bruiners N; Pinn ML; Zimmerman MD; Prideaux B; Dartois V; Gennaro ML; Karakousis PC
    J Antimicrob Chemother; 2016 Jun; 71(6):1570-7. PubMed ID: 26903278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice.
    Dutta NK; Bruiners N; Zimmerman MD; Tan S; Dartois V; Gennaro ML; Karakousis PC
    J Infect Dis; 2020 Mar; 221(7):1079-1087. PubMed ID: 31605489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin increases the in vivo activity of the first-line tuberculosis regimen.
    Skerry C; Pinn ML; Bruiners N; Pine R; Gennaro ML; Karakousis PC
    J Antimicrob Chemother; 2014 Sep; 69(9):2453-7. PubMed ID: 24855121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.
    Clemens DL; Lee BY; Silva A; Dillon BJ; Masleša-Galić S; Nava S; Ding X; Ho CM; Horwitz MA
    PLoS One; 2019; 14(5):e0215607. PubMed ID: 31075149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models.
    Robertson GT; Scherman MS; Bruhn DF; Liu J; Hastings C; McNeil MR; Butler MM; Bowlin TL; Lee RB; Lee RE; Lenaerts AJ
    J Antimicrob Chemother; 2017 Mar; 72(3):770-777. PubMed ID: 27999020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.
    Williams KN; Brickner SJ; Stover CK; Zhu T; Ogden A; Tasneen R; Tyagi S; Grosset JH; Nuermberger EL
    Am J Respir Crit Care Med; 2009 Aug; 180(4):371-6. PubMed ID: 19520903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria.
    Liu Y; Pertinez H; Ortega-Muro F; Alameda-Martin L; Harrison T; Davies G; Coates A; Hu Y
    J Antimicrob Chemother; 2018 Mar; 73(3):724-731. PubMed ID: 29244108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
    Ahmad Z; Nuermberger EL; Tasneen R; Pinn ML; Williams KN; Peloquin CA; Grosset JH; Karakousis PC
    J Antimicrob Chemother; 2010 Apr; 65(4):729-34. PubMed ID: 20123722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Adjunctive Therapy Does Not Improve the Sterilizing Activity of the First-Line Antitubercular Regimen in Mice.
    Dutta NK; Pinn ML; Karakousis PC
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models.
    Ahmad Z; Fraig MM; Pinn ML; Tyagi S; Nuermberger EL; Grosset JH; Karakousis PC
    J Antimicrob Chemother; 2011 Jul; 66(7):1560-6. PubMed ID: 21602551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.
    Tyagi S; Ammerman NC; Li SY; Adamson J; Converse PJ; Swanson RV; Almeida DV; Grosset JH
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):869-74. PubMed ID: 25561537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.
    Lanoix JP; Betoudji F; Nuermberger E
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1091-6. PubMed ID: 26643352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
    de Knegt GJ; Bakker-Woudenberg IA; van Soolingen D; Aarnoutse R; Boeree MJ; de Steenwinkel JE
    Int J Antimicrob Agents; 2015 Jul; 46(1):66-72. PubMed ID: 25951996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
    Kaushik A; Ammerman NC; Tasneen R; Story-Roller E; Dooley KE; Dorman SE; Nuermberger EL; Lamichhane G
    J Antimicrob Chemother; 2017 Aug; 72(8):2320-2325. PubMed ID: 28575382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.
    De Groote MA; Gilliland JC; Wells CL; Brooks EJ; Woolhiser LK; Gruppo V; Peloquin CA; Orme IM; Lenaerts AJ
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1237-47. PubMed ID: 21135176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model.
    Baijnath S; Moodley C; Ngcobo B; Singh SD; Kruger HG; Arvidsson PI; Naicker T; Pym A; Govender T
    Int J Antimicrob Agents; 2018 Jan; 51(1):77-81. PubMed ID: 28843822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.